HuiKang Bio-tech--A life science explorer for 20 years, an expert in protein and peptides application, an advocate of biological original medicine, and an innovator in the field of medical skin care
Taking recombinant human lysozyme eye drop as a representative, we have developed original biological new drugs and class I new biological products.
Taking absorbable gene recombinant human collagen hemostatic sponge and cosmetic medicine postoperative cold compress as representatives, we innovates bionic medical devices.
HuiKang Research Institute
HuiKang Bio-tech has a professional scientific research team with more than 60 experts, including industry elites and distinguished university professors. The proportion of researchers accounted for 23%, including 6 doctors. The team has maintained long-term exchanges and cooperation with oversea biological experts and scholars from Australia and South Korea. It has cooperated with 7 domestic and foreign universities in scientific research projects, and undertaken 12 national provincial and municipal scientific research projects.
Founder of HuiKang Bio-Tech Pharmaceuticals R&D Center
Major in microbiology, senior engineer, expert in protein and peptides drug research and development
Leader of HuiKang Bio-Tech Cosmetics R&D Center
Engaged in the traditional Chinese medical treatment industry in his early career, and then devoted to the study of aromatherapy.
Chief scientist of HuiKang Bio-Tech
Graduated from the Fourth Military Medical University, engaged in pharmacological toxicology research.
Director of Biotechnology in Pharmaceuticals R & D Center
Graduated from the Fourth Military Medical University, mainly engaged in infection immunology research.
Director of Chemical Technology in Pharmaceuticals R & D Center
Mr.Liu graduated from Manchester University and he engaged in the research of Chinese medicine as well the synthesis and analysis of active peptides
HuiKang Bio-Tech Dermatologist
Graduated from the Chinese Peking Union Medical College, he is mainly engaged in the construction of vitro three-dimensional skin model (artificial skin) and the vitro detection of allergens and skin irritants with artificial skin.
Director of Pharmaceuticals R & D Center
Clinical medicine major, senior engineer, expert in peptide synthesis, one of the earliest engineers engaged in large-scale peptide synthesis research in China.
Director of Pharmaceuticals R & D Center
He is a committee member of the Clinical Immunology Committee of Shaanxi Immunology Association and graduated from the Fourth Military Medical University.
Director of Genetic Engineering Department of Pharmaceuticals R & D Center
Deputy senior researcher，graduated from Southwest Jiaotong University，engaged in molecular biology research
Director of Peptides Engineering Department of Pharmaceuticals R & D Center
Deputy senior researcher，graduated from Shaanxi Normal University，mainly engaged in peptides synthesis technology, peptides cosmetics, and peptides medicine raw materials development.
Director of Preparation Engineering Department of Pharmaceutical R&D center
Deputy senior researcher，graduated from Lanzhou University，he has been engaged in the purification of bioactive proteins and the development&application of related pharmaceutical products.
China Peptide Bank
This project plans to construct a commercial peptide bank, or parallel peptide bank, with more than 175,000 peptides, named HuiKang International Peptide Bank(China Peptide Bank).
HuiKang International Peptide Bank(China Peptide Bank) contains abundant unknown active epitope peptide information, and will become a treasure house shared by human beings after its completion. In addition to the screening of leading active epitope peptides in the field of biomedical research, it can also provide active peptides for screening in pharmaceutical, food, health care products, cosmetics, catalysts and materials. It is a basic or strategic project of biomedical R&D innovation in China and even in the world. It will make immeasurable contribution to the research of human life science, and has great social and economic benefits.View Details
Biotechnology Industrial Park
HuiKang Biotechnology Industrial Park, with 520 million yuan investment, covering an area of 42 mu and construction area of 65,000 ㎡, is in accordance with the concept of international standard workshop, high-tech products, modern management and leap-forward development for planning and design, which integrates scientific research, management, training and production as one. It has 9,000㎡ cosmetic products and lyophilized powder production line, with production capacity of 2,500,000 pcs/month.View Details
Shaanxi HuiKang Bio-Tech Co.,Ltd. Tel. 029-8452 6330 Add. 56 Yuyue Road, Yuhua Industrial Park, Yanta District, Xi 'an, Shaanxi